NASDAQ NMS - GLOBAL MARKET · BVS
-2.38% · -$0.3200 · Vol 362.4K
Market closed · last close 4:00 PM ET · price as of 16:01:28 ET
Bioventus Inc

Bioventus Inc

Health Care
$13.13
Card
Relationship Map

Follow $BVS

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BVS by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
BVS
Bioventus Inc
Fri Oct 2 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

79/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 6 of 6 factors measured · Fri Oct 2 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BVS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BVS catalysts
About Bioventus Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2021
Employees
950
Country
US

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$13.52
Day high
$13.52
Day low
$13.02
Previous close
$13.45
52W high
$15.26
-13.96% from high
52W low
$6.51
76% of range
Market cap
$896.8M
P/E
19.60×
EPS
$0.6700
Beta
-0.10
Shares out
68.3M
Volume
362.4K
0.71× rel vol
Avg volume
507K
VWAP
$13.18
Price history computed in-house
1W
-6.35%
1M
-6.68%
3M
+14.27%
1Y
+87.04%
YTD
+76.48%
SMA 50 $13.66 · below
SMA 200 $10.28 · above
52W position 76%

BVS overview

Loading financial statements
Loading BVS Form 4 filings
Public disclosures

Congress activity in BVS

No receipt-qualified Congressional disclosure is present for BVS in the cached public ledger.

Federal contracts

BVS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BVS in this window.
Lobbying spend

BVS lobbying filings, year to date.

Registered lobbying filings matched to Bioventus Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BVS in this window.
Loading news for BVS
Analyst ratings
Sovereign unlock shows live analyst consensus for BVS.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.